9/1/16 18:18 | 8/30/16 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Payan Donald G | CA | DO | EVP,P Di | S | -21 | 4.00 | 16 | -5 | -9 | 53 | I | 31 | 17 | 36 | 30 | 51 | 20 | 20 | 29 | -1 | -1 | 7 | -25 | -18 | |
6/12/15 19:22 | 6/10/15 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Payan Donald G | CA | DO | EVP,P Di | M.d | 89 | 2.14 | 3 | 42 | 250 | 58 | D | -4 | -15 | 47 | -1 | -18 | -5 | -1 | -3 | 1 | -4 | -10 | -12 | -12 | -32 |
6/12/15 19:22 | 6/10/15 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Payan Donald G | CA | DO | EVP,P Di | S.d | -153 | 3.68 | 3 | -42 | -42 | 58 | D | -4 | -15 | 47 | -1 | -18 | -5 | -1 | -3 | 1 | -4 | -10 | -12 | -12 | -32 |
4/3/15 20:35 | 4/1/15 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Payan Donald G | CA | DO | EVP,P Di | S | -38 | 3.75 | 3 | -10 | -15 | 58 | D | -52 | -4 | 82 | 60 | 43 | 1 | 12 | 9 | 4 | 7 | 24 | -17 | -32 | -37 |
9/5/14 18:07 | 9/3/14 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Payan Donald G | CA | DO | EVP,P Di | S | -51 | 2.56 | 1 | -20 | -23 | 68 | D | -74 | -24 | -46 | -32 | -27 | -9 | -8 | -5 | 0 | -2 | -18 | -4 | 48 | 22 |
2/26/14 19:21 | 2/24/14 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Payan Donald G | CA | DO | EVP,P Di | S | -74 | 3.71 | 2 | -20 | -18 | 88 | D | -63 | -45 | 0 | 30 | 10 | 25 | 15 | 12 | 0 | 3 | 8 | -8 | -25 | -12 |
6/20/12 17:45 | 6/19/12 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Payan Donald G | CA | DO | EVP,P Di | S | -87 | 8.70 | 2 | -10 | -8 | 108 | D | 24 | 7 | 24 | 7 | 5 | 19 | 14 | 7 | 0 | 1 | 14 | 18 | -27 | -56 |
1/6/09 19:52 | 1/2/09 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Payan Donald G | CA | DO | EVP,P Di | M.d | 6 | 1.80 | 3 | 3 | 3 | 118 | D | -29 | -63 | -61 | -59 | 59 | 18 | 4 | 0 | -2 | -7 | -27 | -28 | 32 | 10 |